Assessing current AI trends in drug development: Adoption and transformation (part 1)

Published on October 31, 2024

Pharmaceutical R&D is undergoing significant changes. The need to accelerate drug development and enhance decision-making has placed artificial intelligence (AI) at the core of industry transformation. According to Norstella’s State of the Industry AI survey, 2024, 81% of organizations already use AI in at least one development program. This reveals that AI is rapidly becoming […]

Continue reading on website
Other news

Abzena Announces Major Expansion in Microbiology Laboratory Space in Support of Biologic Manufacturing

October 30, 2024
Increased Capacity, Efficiency, and Tools Help Abzena Ensure Higher Standards of Quality for CustomersSan Diego, CA – October 30, 2024 – Abzena, the leading end-to-end integrated CDMO for complex biologics and bioconjugates announced a significant expansion in their quality control (QC) testing capabilities at their San Diego, CA biologics development and cGMP manufacturing site. The new laborator

Abzena’s advanced drug development showcased at CPHI Milan

November 1, 2024
At CPHI Milan 2024, Abzena showcased its latest innovations in cell line development and ADC manufacturing, featuring the advanced AbZelectPRO™ platform and ThioBridge™ linker technology.By offering comprehensive, integrated solutions, Abzena aims to streamline drug development processes and minimize risks for customers, helping to accelerate timelines and enhance production. Outsourcing Pharma (O